Vaccines

Featured

Are partnerships the key to making critical progress in Global Health?

When it comes to Global Health, there are a number of challenges that the global health community should be aware of and focused on. Many Read More

Realistic portrayal of the scientific community needed to combat science denial

With the recent release of the movie “Vaxxed: From Cover-Up to Catastrophe,” I’m seeing a few blog posts and articles pop up about the hegemonic Read More

Science, global health, and irrational health behaviors

Ed. Note: Sara Gorman will be joining us once a month to highlight different aspects of her forthcoming book on science denialism.  Have you ever Read More

Latest

Are partnerships the key to making critical progress in Global Health?

When it comes to Global Health, there are a number of challenges that the global health community should be aware of and focused on. Many Read More


Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus…

AbstractCost-effectiveness thresholds (CETs) based on the Commission on Macroeconomics and Health (CMH) are extensively used in low- and middle-income countries (LMICs) lacking locally defined CETs.


WHO To Review Data On Sanofi Dengue Vaccine Risks; Brazil Joins Philippines In Restricting…

Reuters: Trouble mounts for Sanofi dengue vaccine over safety concerns “The World Health Organization said on Monday it hopes to review safety data on Sanofi’s dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some…More


Investment In R&D For New TB Vaccines Critical To Ending Epidemic

The Hill: Tuberculosis epidemic desperately needs new vaccination strategies José Luis Castro, executive director of the International Union Against Tuberculosis and Lung Disease “…To defeat the TB epidemic, we need nothing short of a research-and-development revolution. … Currently, investment in TB research and development — especially in vaccines — is embarrassingly low. … We must…More


Gavi To Purchase $85M In Typhoid Vaccines To Immunize Children In Endemic Nations

Reuters: Vaccine alliance backs typhoid shots for poor with $85 million “The Gavi global vaccine alliance has earmarked $85 million to help support the introduction of typhoid vaccines in poor countries where millions of children are at risk of the often deadly disease. The funds, agreed by GAVI at a meeting on Thursday, will go…More


MSF Calls On Gavi To Prioritize Children’s Health In Its Funding Model

Médecins Sans Frontières: MSF Press Statement: 20 countries about to fall off Gavi funding ‘cliff,’ risking their ability to pay for lifesaving vaccines for children long term “As the board of directors of Gavi, the Vaccine Alliance, meets this week in Vientiane, Laos, the international medical humanitarian organization Médecins Sans Frontières (MSF) is calling on…More


Aid Workers, Vaccines Arrive In Yemen After Loosening Of Port Blockades; Aid Organizations Warn…

Associated Press: UNICEF: Vaccines cargo to blockaded Yemen can’t be one-off “The U.N. child agency said Sunday that it has flown 1.9 million doses of vaccines to war-torn Yemen, its first aid delivery since a Saudi-led coalition fighting Shiite rebels tightened a sea and air blockade earlier this month. Regional UNICEF Director Geert Cappelaere described…More


Without Reopening Of Ports, Yemen Set To Run Out Of Fuel, Vaccines In 1 Month, UNICEF Says

The Guardian: ‘Only God can save us’: Yemeni children starve as aid is held at border “…Seven million people are on the brink of famine in war-torn Yemen, which was already in the grip of the world’s worst cholera outbreak when coalition forces led by Saudi Arabia tightened its blockade on the country last week,…More


U.S. Should Strengthen Investments In Global Health R&D

The Hill: Let’s tackle new health threats before they reach us Mark Dybul, professor of medicine at the Georgetown University Medical Center, former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and former U.S. Global HIV/AIDS Coordinator “…The need for research to develop new drugs, vaccines, and cures is clear. ……More


Is the Future of Global Healthcare Made in China?

On the 15th of August 2017 the newly appointed director of WHO Tedros Adhanom made his first official visit to China. After three days Tedros left with a pledge of 20 million dollars more and a clarified plan to use China’s One belt One Road initiative as the backbone of global healthcare reforms targeting women, children, teens and emergencies. This is just the latest in China’s growing trend of commitment to global health, clearly a different tone than that being set by US President Donald Trump whose most recent budget proposal saw him attempting to slash international healthcare funding by 1/3. Although China has been engaging in health aid from the Mao era on, China’s “global health” journey really began eleven years ago for China, after the SARS epidemic, with an overhaul of their own healthcare system called the Rural Co-operative Medical Care System. This initiative extended healthcare options to China’s 800 million rural resident and expanded China’s current healthcare coverage to 94.7% of its population


National Geographic Examines International Efforts To Improve Access To Vaccines To Prevent…

National Geographic: Here’s Why Vaccines Are So Crucial “…[F]rom the vantage of a country like the United States, it can be easy to imagine that the most pressing vaccine challenge of 2017 lies in convincing certain communities of skeptical parents that they really ought to inoculate their kids. Those efforts are important, to be sure.…More


Let’s get political…

The ninth edition of the World Health Summit (WHS) was held during October 15th -17th, in a nice former cinema hall in the city of East Berlin, built in the early 1960s and with a rather appropriate name for the occasion, “Kosmos”.  This year, the event was attended by 2,000 participants from 100 countries, all aiming “to improve healthcare all over the world”. Well, at least, that’s the idea. Although I was a bit afraid this would be a “mini Davos-like” event, as described (arguably, by a biased observer)  in past editions, it was surprising and even encouraging to see a good demographic balance, with very young students and professionals, as well as senior high-profile researchers, decision-makers and CEOs from pharmaceutical companies, among other usual suspects. Even a royal member of the Kingdom of Jordan, Princess Dina Mired, actively participated as the President-Elect of the Union for International Cancer Control


Experimental Ebola Vaccines Provide Year-Long Antibody Responses In Liberia Trial

CIDRAP News: Liberia trial finds Ebola vaccines yield year-long immune response “A trial at the end of Liberia’s Ebola outbreak of two candidate vaccines that were furthest along in development at the time showed both posed no major safety concerns and triggered immune responses that lasted at least a year, researchers from a U.S.-Liberian clinical…More


U.N. Seeks More Funds To Address Rohingya Refugee Crisis In Bangladesh; WHO Sends Cholera…

Devex: In Bangladesh, an unfolding humanitarian crisis “…Now, nearly six weeks on from the start of the crisis, conditions in the camps [in Cox’s Bazar, Bangladesh,] are still being described as chaotic as thousands of exhausted, traumatized Rohingya, a persecuted Muslim minority, continue to pour in daily, and aid agencies struggle to handle the influx.…More


« Newer PostsOlder Posts »